316 related articles for article (PubMed ID: 833262)
1. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.
Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624
[TBL] [Abstract][Full Text] [Related]
3. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
Rahimy MH; Ryan KK
Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay for serum medroxyprogesterone acetate in Thai women receiving injectable DMPA contraceptive.
Werawatgoompa S; Pongpradit T; Leepipatpaiboon S; Sukanthanak A
Contraception; 1979 Oct; 20(4):319-27. PubMed ID: 509958
[TBL] [Abstract][Full Text] [Related]
5. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea.
Jeppsson S; Johansson ED; Ljungberg O; Sjöberg NO
Acta Obstet Gynecol Scand; 1977; 56(1):43-8. PubMed ID: 842303
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
Mishell DR
J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera.
Mora G; Johansson ED
Contraception; 1976 Sep; 14(3):343-50. PubMed ID: 824097
[TBL] [Abstract][Full Text] [Related]
8. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women.
Rahimy MH; Ryan KK; Hopkins NK
Contraception; 1999 Oct; 60(4):209-14. PubMed ID: 10640167
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Jeppsson S; Gershagen S; Johansson ED; Rannevik G
Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
[TBL] [Abstract][Full Text] [Related]
10. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study.
Lan PT; Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
Contraception; 1984 Jan; 29(1):1-18. PubMed ID: 6234145
[TBL] [Abstract][Full Text] [Related]
11. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
12. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.
Petta CA; Faúndes A; Dunson TR; Ramos M; DeLucio M; Faúndes D; Bahamondes L
Fertil Steril; 1998 Nov; 70(5):817-20. PubMed ID: 9806559
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of different doses of Depo Provera.
Fotherby K; Koetsawang S; Mathrubutham M
Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem in Chinese women.
Zhou XF; Shao QX; Han XJ; Weng LJ; Sang GW
Contraception; 1998 Jun; 57(6):405-11. PubMed ID: 9693401
[TBL] [Abstract][Full Text] [Related]
15. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
16. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
Rahimy MH; Cromie MA; Hopkins NK; Tong DM
Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166
[TBL] [Abstract][Full Text] [Related]
17. Serum follicle-stimulating hormone, luteinizing hormone and progesterone concentrations in pseudopregnant rats treated with medroxyprogesterone acetate.
de Greef WJ; Dullaart J; Zeilmaker GH
J Endocrinol; 1976 Sep; 70(3):465-71. PubMed ID: 978105
[TBL] [Abstract][Full Text] [Related]
18. Effect of depo-medroxyprogesterone acetate on serum progesterone levels when administered on various cycle days.
Siriwongse T; Snidvongs W; Tantayaporn P; Leepipatpaiboon S
Contraception; 1982 Nov; 26(5):487-93. PubMed ID: 6218964
[TBL] [Abstract][Full Text] [Related]
19. Ovarian function following a single administration of depo-medroxyprogesterone acetate (DMPA) at different doses.
Bassol S; Garza-Flores J; Cravioto MC; Diaz-Sanchez V; Fotherby K; Lichtenberg R; Perez-Palacios G
Fertil Steril; 1984 Aug; 42(2):216-22. PubMed ID: 6235131
[TBL] [Abstract][Full Text] [Related]
20. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. III. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depot-medroxyprogesterone acetate (DMPA).
Aedo AR; Landgren BM; Diczfalusy E
Contraception; 1981 Aug; 24(2):117-35. PubMed ID: 6457729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]